ReNeuron Group plc RQE1.F Stock
ReNeuron Group plc Price Chart
ReNeuron Group plc RQE1.F Financial and Trading Overview
| ReNeuron Group plc stock price | 0.03 EUR |
| Previous Close | 0.1 EUR |
| Open | 0.08 EUR |
| Bid | 0.08 EUR x 0 |
| Ask | 0.11 EUR x 0 |
| Day's Range | 0.08 - 0.08 EUR |
| 52 Week Range | 0.001 - 0.35 EUR |
| Volume | 2K EUR |
| Avg. Volume | 178 EUR |
| Market Cap | 26.37M EUR |
| Beta (5Y Monthly) | 1.07816 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RQE1.F Valuation Measures
| Enterprise Value | -5817411 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 49.758522 |
| Price/Book (mrq) | 0.9261364 |
| Enterprise Value/Revenue | -10.976 |
| Enterprise Value/EBITDA | 0.838 |
Trading Information
ReNeuron Group plc Stock Price History
| Beta (5Y Monthly) | 1.07816 |
| 52-Week Change | -95.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.35 EUR |
| 52 Week Low | 0.001 EUR |
| 50-Day Moving Average | 0.05 EUR |
| 200-Day Moving Average | 0.14 EUR |
RQE1.F Share Statistics
| Avg. Volume (3 month) | 178 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 57.17M |
| Float | 46.27M |
| Short Ratio | N/A |
| % Held by Insiders | 19.96% |
| % Held by Institutions | 30.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1342.45% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.97% |
| Return on Equity (ttm) | -72.37% |
Income Statement
| Revenue (ttm) | 530K EUR |
| Revenue Per Share (ttm) | 0.009 EUR |
| Quarterly Revenue Growth (yoy) | -73.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | -6945000 EUR |
| Net Income Avi to Common (ttm) | -5408000 EUR |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.15M EUR |
| Total Cash Per Share (mrq) | 0.13 EUR |
| Total Debt (mrq) | 421K EUR |
| Total Debt/Equity (mrq) | 8.33 EUR |
| Current Ratio (mrq) | 2.046 |
| Book Value Per Share (mrq) | 0.088 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7484000 EUR |
| Levered Free Cash Flow (ttm) | -6299375 EUR |
Profile of ReNeuron Group plc
| Country | Germany |
| State | N/A |
| City | Pencoed |
| Address | Pencoed Business Park |
| ZIP | CF35 5HY |
| Phone | 44 20 3819 8400 |
| Website | https://www.reneuron.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Q&A For ReNeuron Group plc Stock
What is a current RQE1.F stock price?
ReNeuron Group plc RQE1.F stock price today per share is 0.03 EUR.
How to purchase ReNeuron Group plc stock?
You can buy RQE1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ReNeuron Group plc?
The stock symbol or ticker of ReNeuron Group plc is RQE1.F.
Which industry does the ReNeuron Group plc company belong to?
The ReNeuron Group plc industry is Biotechnology.
How many shares does ReNeuron Group plc have in circulation?
The max supply of ReNeuron Group plc shares is 66.42M.
What is ReNeuron Group plc Price to Earnings Ratio (PE Ratio)?
ReNeuron Group plc PE Ratio is now.
What was ReNeuron Group plc earnings per share over the trailing 12 months (TTM)?
ReNeuron Group plc EPS is -0.1 EUR over the trailing 12 months.
Which sector does the ReNeuron Group plc company belong to?
The ReNeuron Group plc sector is Healthcare.